A. Dirican Et Al. , "Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines," JOURNAL OF BUON , vol.19, no.4, pp.1055-1061, 2014
Dirican, A. Et Al. 2014. Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines. JOURNAL OF BUON , vol.19, no.4 , 1055-1061.
Dirican, A., Erten, C., ATMACA, H., Bozkurt, E., KÜÇÜKZEYBEK, Y., Varol, U., ... TARHAN, M. O.(2014). Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines. JOURNAL OF BUON , vol.19, no.4, 1055-1061.
Dirican, Ahmet Et Al. "Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines," JOURNAL OF BUON , vol.19, no.4, 1055-1061, 2014
Dirican, Ahmet Et Al. "Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines." JOURNAL OF BUON , vol.19, no.4, pp.1055-1061, 2014
Dirican, A. Et Al. (2014) . "Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines." JOURNAL OF BUON , vol.19, no.4, pp.1055-1061.
@article{article, author={Ahmet Dirican Et Al. }, title={Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines}, journal={JOURNAL OF BUON}, year=2014, pages={1055-1061} }